Skip to main content
Figure 6 | Journal of Neuroinflammation

Figure 6

From: Neutralization of chemokine-like factor 1, a novel C-C chemokine, protects against focal cerebral ischemia by inhibiting neutrophil infiltration via MAPK pathways in rats

Figure 6

The effect of anti-CKLF1 antibody on myeloperoxidase (MPO) activity. Anti-CKLF1 antibody (0.1, 0.5 or 1 μg) was injected into the right cerebral ventricle immediately after reperfusion. MPO activity was measured in ischemic cortex. Treatment with anti-CKLF1 antibody inhibited the MPO activity in rat ischemic cortex. Each data point shows the mean ± SEM for five rats. ## P < 0.01, compared with sham-operated group; *P < 0.05, compared with vehicle group.

Back to article page